Insider Activity of Levy Adam D.
According to the SEC Form 4 filings, Levy Adam D., being in a position of
- Chief Financial Officer at Acrivon Therapeutics, Inc. Common Stock,оver the last 12 months, has bought 8832 shares for $14,999, and sold 1142 shares for $1,793,over all time since 2026-01-14, has bought 8832 shares for $14,999, and sold 1142 shares for $1,793.
Biography of Levy Adam D.
No biography is available at this moment.